Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice

39Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

From the age of 3 months until their natural death, female Swiss-derived SHR mice were given melatonin with their drinking water (2 or 20mg/l) for 5 consecutive days every month. Intact mice served as controls. There were 54 mice in each group. The results of this study show that the treatment of melatonin did not significantly influence food consumption, but its administration at lower doses did decrease the body weight of mice; it slowed down the age-related switching-off of estrous function; it did not influence the frequency of chromosome aberrations in bone marrow cells; it did not influence mean life span; and it increased life span of the last 10% of the survivors in comparison to controls. We also found that treatment with low dose melatonin (2mg/l) significantly decreased spontaneous tumor incidence (by 1,9-fold), mainly mammary carcinomas, in mice whereas higher doses (20mg/l) failed to influence tumor incidence as compared to controls. For this reason, we conclude that the effect of melatonin as a geroprotector is dose-dependent. © 2002 Published by Elsevier Science Inc.

Cite

CITATION STYLE

APA

Anisimov, V. N., Alimova, I. N., Baturin, D. A., Popovich, I. G., Zabezhinski, M. A., Rosenfeld, S. V., … Yashin, A. I. (2003). Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice. Experimental Gerontology, 38(4), 449–461. https://doi.org/10.1016/S0531-5565(02)00240-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free